Odonate IncOTC Pink - Limited Information:ODTC
- LAST PRICE17,050.0000
- TODAY'S CHANGE (%)-50.0000 (-0.2924%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close17,050.0000 / 17,100.0000
- Day Range
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ODTC |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Odonate Inc | 50.0M | -1,254.8x | --- |
Lexaria Bioscience Corp | 48.9M | -7.6x | --- |
Bright Green Corp | 45.0M | -3.7x | --- |
KALA BIO Inc | 32.3M | -0.5x | --- |
China Health Industries Holdings Inc | 30.2M | -22.2x | --- |
Acasti Pharma Inc | 26.6M | -1.9x | --- |
Company Information
Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.
Contact Information
- Headquarters
- 4747 Executive Drive Ste 210SAN DIEGO, CA, United States 92121
- Phone
- 858-200-3830
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Kevin Tang
- Chief Financial Officer
- Michael Hearne
- Director
- Robert Rosen
- Independent Director
- Aaron Davis
- Independent Director
- Laura Douglass
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.9K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.15 |
EPS | $-13.59 |
Book Value | $17.65 |
P/E Ratio | -1,254.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
